[On the clinical picture and therapy of bacterial shock and the generalized Sanarelli-Shwartzman phenomenon].
D000022:Abortion, Spontaneous / Q000150:complications; D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000150:complications; D005342:Fibrinolysis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011817:Rabbits; D012772:Shock, Septic / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D012790:Shwartzman Phenomenon / Q000175:diagnosis* / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use; D013916:Thrombelastography; D014665:Vasodilator Agents / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014665:Vasodilator Agents; D006493:Heparin; D013300:Streptokinase
Zur Klinik und Therapie des bakteriellen Schock und des generalisierten Sanarelli-Shwartzman-Phänomen.